Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.10.12.681859

Resolving Cellular Morphology in the Human Brain with Multiparametric Diffusion MR Spectroscopy

Abstract

Diffusion-weighted magnetic resonance spectroscopy (dMRS) noninvasively probes the diffusion of mostly intracellular metabolites and can therefore report on brain microstructure with a cell-type specificity that water-based diffusion MRI cannot achieve. However, the morphological information accessible to conventional dMRS is limited: estimating both cell-body (soma) and neurite dimensions from a single diffusion-encoding scheme is an ill-posed problem, and neither ultra-high b-value nor diffusion-time-dependent measurements alone distinguish soma size from neurite radius. Here we introduce multiparametric dMRS in the human brain, combining diffusion-time- dependent encoding (apparent diffusion coefficient, ADC, and diffusion kurtosis, K, sampled over diffusion times of 6 ms to 250 ms and b-values up to 8 ms {micro}m-2) with double-diffusion-encoded spectroscopy (DDES). Using Monte-Carlo analysis, we show that fitting a two-compartment (soma + neurite) tissue model to diffusion-time data alone is degenerate, admitting two near-indistinguishable solutions. Adding the orthogonal angular information from DDES breaks this degeneracy: jointly fitting both experiments converges to a single, biophysically plausible solution irrespective of initialization, yielding cell-type- specific estimates of intrinsic diffusivity, soma radius, neurite radius, and neurite signal fraction for neuronal (NAA, glutamate) and glial (choline, myo-inositol) metabolites. Metabolite microscopic anisotropy approaches unity, consistent with predominantly intra-neurite diffusion, while simultaneously acquired water data reveal short-range structural disorder and intercompartmental exchange ({approx}15 ms). Multiparametric dMRS thus extends the standard model of metabolite diffusion by a soma compartment and offers a route toward in vivo, cell-type- specific morphometry of neurons and glia in humans--a foundation for biomarkers in conditions where soma and neurite morphology are altered.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Doering, A., Roeseler, F., Simsek, K., Afzali, M., Kreis, R., Landheer, K., Jones, D. K., Valette, J., Palombo, M.. 2025-10-13. Resolving Cellular Morphology in the Human Brain with Multiparametric Diffusion MR Spectroscopy. https://doi.org/10.1101/2025.10.12.681859

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗